Myopia control is vital for children with fast myopia progression. What are the key risk factors for faster myopia progression? What clinical findings indicate a more proactive myopia management strategy may be required? This case describes risk factors and evidence-based treatment options for fast myopia progressors.
A sample of slow and fast progressors in prior 24 month orthokeratology clinical trials were found to have the same baseline refraction and axial length. The slow progressors were older, and showed 0.5mm smaller treatment zone diameters (TZDs), but no difference in induced peripheral myopic shift. There was also no direct correlation between TZD and axial elongation, indicating an intriguing but not yet defined relationship.
There are numerous reasons why contact lenses are beneficial for children, and the safety profile is high. Yet there are still barriers in the mind of the practitioner, parent and young patient to childhood CL wear. Here we address these often cited barriers, with the goal to support your clinical communication on the benefits and safety of contact lenses for kids, to move towards achieving a ‘yes’ from the parent and patient.
If a child is wearing spectacles or using atropine as their primary myopia control treatment, which contact lens should we choose for sports? Is a myopia controlling contact lens needed if it will only be for occasional wear? Here we discuss the options and clinical considerations based on the individual patient.
How do you manage your young patient when their ophthalmologist appears to have advised parents against orthokeratology? How should you communicate with the ophthalmologist about orthokeratology? This clinical case explores the aspects of safety, efficacy and benefits, including detail on the comparison of short-term risks of contact lens wear with the long-term risks of myopia.
This study evaluates how orthok treatment zone diameter influences change in refraction and axial eye length over 1-year in children previously fit with orthok lenses of varying back optic zone diameter, to reveal that where treatment zone diameter was less than pupil diameter orthok’s myopia control efficacy appeared to be improved.